F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Provide pharmaceutical services to meet the needs of each resident and employ or obtain the services of a
licensed pharmacist.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview, and record review, the facility failed to provide pharmaceutical services, including
procedures that assure the accurate acquiring and administering of all drugs to meet the needs of the
residents, for one resident (R#1) of three residents reviewed for pharmacy services. The facility failed to
ensure physician ordered, Ingrezza 80 mg (a medication treatment of tardive dyskinesia) was provided as
scheduled on [DATE], [DATE], [DATE] and [DATE]. This failure placed residents at risk for harm by not
receiving the therapeutic effects of this medication prescribed. The findings were:Record review of R#1's
face sheet dated [DATE] revealed R#1 was 68 years-old female and was admitted to the facility on [DATE].
R#1's diagnoses included Pneumonia (infection of the lungs), Acute respiratory failure (not enough oxygen
in the body), anxiety disorder (excessive feelings of fear). Record review of R#1's Quarterly Minimum Data
Set (MDS) assessment, dated [DATE], revealed R#1 BIMS score could not be determined and resident's
mental status has not changed. The resident was dependent and was using a feeding tube. The resident's
orders include Anticonvulsant, Antianxiety and Antipsychotic medicationsRecord review of R#1's care plan,
dated [DATE], revealed R#1 was at risk for changes to mood due to diagnoses of schizoaffective disorder,
anxiety and insomnia. The resident rarely understood and rarely understood others. Record review of R#1's
Orders dated [DATE],revealed the following order: Ingrezza (valbenazine) 80 Mg with an order date of
[DATE] and a start date of [DATE].An observation of R# 1 on [DATE] at 10:57 AM was conducted. R#1 was
lying in bed and appeared to have involuntary body movements. R# 1 was being fed, hydrated and
medicated by a tube. The resident was unable to express herself verbally.An interview with R#1 Family on
[DATE] at 12:28 PM was conducted. R#1 Family revealed that R#1 was not given her medication as
prescribed by the Doctor. R#1 Family stated, the nursing staff had not provided the medication because
they had not ordered it.An interview with the Pharmacy Technician on [DATE] at 2:37 PM was conducted.
The Pharmacy Technician stated the DON called the pharmacy on [DATE] at 11:01 AM and verbally
ordered Ingrezza 80mg for R#1. The Pharmacy Technician advised the DON that a signed order must be
received by the pharmacy before the prescription would be filled. The Pharmacy Technician emailed a form
to the DON. The Pharmacy Technician stated that the DON sent a faxed, signed order on [DATE] at 6:39
AM. The Pharmacy Technician stated, on [DATE] at 10:15 AM the pharmacy faxed to the facility a report
that the prescription was not in stock and that the pharmacy had ordered it from their vendor and it should
be in [DATE] approximately 8 AM.An interview with the Pharmacist on [DATE] at 8:19 AM was conducted.
The Pharmacist confirmed that the DON had been advised by the Pharmacy Technician that the DON
would need to submit a signed order for that prescription. The Pharmacist also confirmed the order wasn't
received until [DATE] at 6:39 AM and that the prescription was not in stock and it had been ordered from
the manufacturer when the order was received. The Pharmacist stated, R#1 was administered medications
via a feeding tube and there were no alternative medications that could be administered by the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
676308
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
676308
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
12/23/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
San Gabriel Rehabilitation and Care Center
4100 College Park Dr
Round Rock, TX 78665
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0755
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
feeding tube. An interview with the DON on [DATE] at 2:15 PM was conducted. The DON stated the orders
for Ingrezza 80 mg were written by the Doctor on [DATE] with a start date of [DATE]. The DON stated, she
had placed a verbal order to the pharmacy on [DATE] and she was asked by the Pharmacy Technician for a
written, signed order. The DON stated, she sent the written, signed order and she didn't find out that the
pharmacy did not have the prescription in stock until Monday morning [DATE]. The DON stated she placed
a follow up call to the pharmacy on [DATE] and she was told the prescription had been ordered from the
manufacturer and the expectation was that it would arrive on [DATE]. The DON stated she could not
preorder the medication because R#1 did not have prescription coverage until [DATE].An Interview with the
Doctor on [DATE] at 4:01 PM was conducted. The Doctor stated he ordered Ingrezza 80 mg. for R#1 on
[DATE] with a start date of [DATE]. The Doctor stated he was working with the Manufacture Representative
to try and get samples delivered to the facility as soon as possible. The Doctor stated if R#1 did not get her
medication her symptoms from Tarda Dyskinesia would return. The Doctor stated, We have studied this
medication, and the patient would not have any escalation of symptoms if she did not get this medication.
The Doctor confirmed he could not prescribe an alternative medication for R#1's condition because this
was the only one of its kind that can be administered via a feeding tube.Record review of the Nursing
Policies and Procedures Medication Management Program revised [DATE], revealed medications are
administered no more than one hour before to one hour after the medication pass time.Record Review of
PHARMACY SERVICES POLICIES AND PROCEDSECTION 7 - MEDICATION
PROCUREMENTSUBJECT: 7.1.0 ACQUISITION OF ROUTINE MEDICATION ORDERSPOLICY:1. The
facility must provide or obtain routine medications and biologicals to meet the needs of each
resident.PROCEDURES1. New admission / readmission / New OrdersA. For hard-copy medical records,
ensure that all medications and biological orders are written, dated and signed by the Physician/Prescriber
lawfully authorized to give such an order. B. Fax hard copy physician/prescriber orders to the pharmacy,
whenapplicable
Event ID:
Facility ID:
676308
If continuation sheet
Page 2 of 2